4.6 Article

Molecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancer

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer

Nitish Kumar et al.

Summary: This article provides an overview of factors causing breast cancer in women and strategies used by researchers worldwide to antagonize ER-alpha.

MOLECULAR DIVERSITY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Endocrinology & Metabolism

Molecular Mechanisms of Endocrine Resistance in Estrogen-Positive Breast Cancer

Esmael Besufikad Belachew et al.

Summary: The estrogen receptor is crucial in the treatment of estrogen receptor-positive breast cancer, with endocrine resistance posing a challenge. Combining drugs that target different signaling pathways and coregulatory proteins with endocrine therapy may offer a novel therapeutic approach to combat endocrine resistance.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Oncology

Aneuploidy as a promoter and suppressor of malignant growth

Anand Vasudevan et al.

Summary: Aneuploidy, although frequent in human tumors, is not always a driver of cancer development and can have tumor-suppressive effects. The specific consequences of aneuploidy are context-dependent and influenced by genetic and environmental factors.

NATURE REVIEWS CANCER (2021)

Review Genetics & Heredity

Context is everything: aneuploidy in cancer

Uri Ben-David et al.

NATURE REVIEWS GENETICS (2020)

Review Oncology

The Landscape of Targeted Therapies in TNBC

Elena Vagia et al.

CANCERS (2020)

Article Oncology

Prevalence of Molecular Subtypes of Breast Cancer: A Single Institutional Experience of 2062 Patients

Prakash Pandit et al.

EUROPEAN JOURNAL OF BREAST HEALTH (2020)

Review Cell Biology

Posh the APC/C E3 Ubiquitin Licase to Orchestrate Cell Division

Edmond R. Watson et al.

TRENDS IN CELL BIOLOGY (2019)

Review Endocrinology & Metabolism

Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy

Aradhana Rani et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Anatomy & Morphology

Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review

Ilhan Elmaci et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)

Review Oncology

Targeted therapies in breast cancer: New challenges to fight against resistance

Viviana Masoud et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)

Review Endocrinology & Metabolism

Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer

J. S. Carroll

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Review Oncology

BRCAness revisited

Christopher J. Lord et al.

NATURE REVIEWS CANCER (2016)

Review Oncology

Role of Estrogen Receptor Signaling in Breast Cancer Metastasis

Sudipa Saha Roy et al.

INTERNATIONAL JOURNAL OF BREAST CANCER (2012)

Review Biochemistry & Molecular Biology

Spindle Poisons and Cell Fate: A Tale of Two Pathways

Daniel R. Matson et al.

MOLECULAR INTERVENTIONS (2011)

Article Biochemistry & Molecular Biology

Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer

Xin Pan et al.

NATURE MEDICINE (2011)

Review Cell Biology

CUEDC2: an emerging key player in inflammation and tumorigenesis

Jianghong Man et al.

PROTEIN & CELL (2011)

Article Oncology

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

Francesca De Amicis et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Review Oncology

ER Re-expression and Re-sensitization to Endocrine Therapies in ER-negative Breast Cancers

Joeli A. Brinkman et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)

Review Oncology

Biological determinants of endocrine resistance in breast cancer

Elizabeth A. Musgrove et al.

NATURE REVIEWS CANCER (2009)

Review Cell Biology

The spindle-assembly checkpoint in space and time

Andrea Musacchio et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome

Pei-Jing Zhang et al.

EMBO JOURNAL (2007)

Article Biotechnology & Applied Microbiology

Discovery of estrogen receptor a target genes and response elements in breast tumor cells

CY Lin et al.

GENOME BIOLOGY (2004)

Article Biochemistry & Molecular Biology

A ubiquitin-binding motif required for intramolecular monoubiquitylation, the CUE domain

SC Shih et al.

EMBO JOURNAL (2003)